Amylin Pharmaceuticals Inc. (AMLN)

[SeriousMoney]

Amylin Pharmaceuticals to Present at UBS Global Life Sciences Conference

SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the UBS Global Life Sciences Conference on Tuesday, September 27, 2005 at 8:00 a.m. ET in New York. Daniel M. Bradbury, Chief Operating Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and recordings will be made available following the event. The webcasts and recordings will be accessible through Amylin's corporate website, located at www.amylin.com. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines.

SOURCE Amylin Pharmaceuticals, Inc. 09/22/2005
CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., [phone], ext. 7272
Web site: http://www.amylin.com (AMLN)

http://investors.amylin.com/phoenix.zhtml?c=101911&p=irol-newsArticle&ID=759717&highligh...